Complexation studies on inositol-phosphates: IV. Ca(II) complexes of myo-inositol 1,4,5-trisphosphate
References (19)
- et al.
Trends Pharmacol. Sci.
(1986) - et al.
J. Biol. Chem.
(1987) - et al.
J. Inorg. Biochem.
(1990) - et al.
Talanta
(1974) - et al.
Nature
(1984) - et al.
Nature
(1984) Biochem. J.
(1984)- et al.
Nature
(1989) JAMA
(1989)
There are more references available in the full text version of this article.
Cited by (15)
Investigation of the ternary D-myo-inositol 1,2,6-tris(phosphate)-spermine-Zn<sup>2+</sup> system in solution
2001, Journal of Inorganic BiochemistryCarbohydrates as ligands: Coordination equilibria and structure of the metal complexes
2000, Coordination Chemistry ReviewsCitation Excerpt :A polysaccharide–iron complex named ‘Nifrex’ obtained from Fe(III)-chloride and Glc is also being used for treatment of iron deficiency anaemia [85,86]. There are many experiments in progress to develop other sugar type ligands like the l-idopyranosiduronic acid — containing oligosaccharides (Sarkar et al. [16]), or modified inositols (Hegetschweiler et al., [39] and Spiess et al. [87,88]). The Zn(II)–HyA complex has been patented and used as a medicine for the treatment of crural ulcer, decubitus and primarily non-healing wounds [89].
Complexation of spermine and spermidine by myo-inositol 1,4,5-tris(phosphate) and related compounds: Biological significance
1996, Biochimica et Biophysica Acta - General SubjectsComplexation studies on inositol-phosphates, VI. Al<sup>3+</sup> complexes of DL-myo-inositol 1,4,5-triphosphate and D-myo-inositol 1,2,6-triphosphate
1995, Journal of Inorganic Biochemistry
Copyright © 1992 Published by Elsevier B.V.